Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nilörngruppen AB in relation to the public offer from AB Traction
Mandate

Vinge advises Nilörngruppen AB in relation to the public offer from AB Traction

April 22, 2009

Vinge is advising the board of directors of Nilörngruppen AB in relation to the public offer from AB Traction published 9 March 2009. Nilörngruppen AB is listed at NASDAQ OMX Stockholm and works with design, manufacturing and sales of labels and label concepts to the fashion and clothing industry.

Vinges advise is provided by Göran Nyström, Mattias Friberg and Johan Syrén.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026